MANILA, Philippines – Troubles continue for French pharmaceutical giant Sanofi Pasteur as the Philippines' Food and Drug Administration (FDA) suspended its sale of the controversial Dengvaxia dengue vaccine for a year.
The FDA, a regulatory agency under the Department of Health (DOH), also imposed a P100,000-administrative fine on ...
January 04, 2018 at 09:53AM
Post a Comment